Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Full year trading statement

10 Jan 2025 07:00

RNS Number : 8294S
Anpario PLC
10 January 2025
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

 

Anpario plc("Anpario", the "Group" or the "Company")

 

Full year trading statement

 

Anpario plc (AIM:ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2024 ("FY 2024"). The figures set out in this announcement remain subject to audit.

 

Trading update

The Group, including three months of trading for Bio-Vet Inc., delivered a stronger than expected operating performance in the second half of 2024. Year-end sales were higher than anticipated, and the Group now expects revenue for the 12 months ended 31 December 2024 to be approximately £37.5m* (31 December 2023: £31.0m). This strong performance in revenue combined with the Group's high operational gearing and favourable year-end foreign exchange movements, will result in adjusted EBITDA being ahead of current market expectations*.

 

Bio-Vet Inc. had a strong final quarter due to heightened demand for its products, which support the health of dairy cows affected by avian influenza, and our Middle East and Africa segment delivered an outstanding sales performance.

 

Financial position

Our financial position remains strong, with year-end cash balances of £10.5m* (31 December 2023: £10.6m), after accounting for the acquisition of Bio-Vet Inc. and associated land and buildings for an initial cash consideration of US$6.3m, on a debt-free basis, which completed in September 2024.

 

Our strong balance sheet enables the Group to invest in innovative natural product solutions, expand our global reach and explore earnings enhancing and complementary acquisitions to continue the profitable development of the Group. We remain confident in our ability to capitalise on growth opportunities, delivering long-term benefits to all stakeholders.

 

FY2024 Results

The Group expects to publish its FY 2024 final results on or around 26 March 2025.

 

 

 

*Analyst consensus for FY 2024 immediately prior to this announcement was Revenue of £35.25m, EBITDA of £5.7m and net cash of £7.2m.

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

Tom Knibbs

Henry Willcocks

Corporate Broking

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUUUGUPAPWB
Date   Source Headline
19th Jul 20072:29 pmRNSBlocklisting Interim Review
16th Jul 20072:00 pmRNSAdditional Listing
12th Jul 200711:30 amRNSTrading Statement
18th Jun 20079:24 amRNSRPM Production Stopped
4th Jun 20074:50 pmRNSDirector/PDMR Shareholding
4th Jun 200711:14 amRNSDirectorate Change
25th May 200710:18 amRNSMine Training Centre
4th May 200712:02 pmRNSDividend Declaration
26th Apr 20077:02 amRNSFinal Results
16th Apr 20073:02 pmRNSDirector/PDMR Shareholding
13th Apr 20073:11 pmRNSDirector/PDMR Shareholding
13th Apr 20073:06 pmRNSRustenburg Directorate
3rd Apr 20072:42 pmRNSDirector/PDMR Shareholding
2nd Apr 200711:17 amRNSDirectorate Change
30th Mar 20073:40 pmRNSAGM Statement
28th Mar 20072:51 pmRNSDirector/PDMR Shareholding
19th Mar 20071:10 pmRNSDividend re-investment
19th Mar 20071:01 pmRNSDirector/PDMR Shareholding
13th Mar 20072:10 pmRNSDividend conversion rate
13th Mar 200711:00 amRNSDirector/PDMR Shareholding
2nd Mar 200712:22 pmRNSDirectorate Change
2nd Mar 20079:34 amRNSRustenburg Platinum
2nd Mar 20079:13 amRNSDirector/PDMR Shareholding
27th Feb 20072:01 pmRNSDirectorate Change
14th Feb 20072:00 pmRNSDirectorate Change
12th Feb 20077:01 amRNSFinal Results
12th Feb 20077:00 amRNSDividend Declaration
18th Jan 20072:40 pmRNSBlocklisting Interim Review
15th Jan 20079:23 amRNSAdditional Listing
12th Jan 20073:30 pmRNSBlocklisting Interim Review
14th Dec 20061:05 pmRNSBEE Transaction
12th Dec 200610:00 amRNSAmandelbult mine
11th Dec 20069:15 amRNSPreference Shares
11th Dec 20069:00 amRNSConversion of pref shares
6th Dec 200611:45 amRNSDirectorate Change
6th Dec 200611:06 amRNSFacility visit
29th Nov 200612:00 pmRNSTrading Statement
27th Nov 200611:56 amRNSResult of EGM
9th Nov 200610:48 amRNSSchedule 1 - Kiotech Int. Plc
9th Nov 20067:00 amRNSFacility visit
8th Nov 20061:02 pmRNSDirector/PDMR Shareholding
8th Nov 200612:00 pmRNSBEE Transaction
7th Nov 20067:01 amRNSDirectorate Change
3rd Nov 20062:00 pmRNSAnooraq-Platinum Proj Update
3rd Nov 20067:30 amRNSRestoration- Kiotech Intl plc
3rd Nov 20067:30 amRNSAcquistion and Placing
27th Oct 20068:52 amRNSDividend Declaration
13th Oct 200611:30 amRNSStatement re. Disposal
13th Oct 200611:30 amRNSPossible Acquisition
13th Oct 200611:30 amRNSSuspension - Kiotech Int

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.